(Q41766698)

English

Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry

scientific article published on 27 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry (English)

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

1 reference

based on heuristic

inferred from title

Gaucher's disease

1 reference

based on heuristic

inferred from title

author name string

Jennifer Ibrahim

1

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Lisa H Underhill

2

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

John S Taylor

3

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Jennifer Angell

4

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

M Judith Peterschmitt

5

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

language of work or name

0 references

publication date

27 June 2016

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Molecular Genetics and Metabolism Reports

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

8

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

17-19

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Revised recommendations for the management of Gaucher disease in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

ELIGLUSTAT TARTRATE: Glucosylceramide Synthase Inhibitor Treatment of Type 1 Gaucher Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Phenotype, diagnosis, and treatment of Gaucher's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Gaucher disease: review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

18 August 2018

Eliglustat tartrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.06.003

7 January 2021

Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.06.003

7 January 2021

Identifiers

10.1016/J.YMGMR.2016.06.003

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41766698&oldid=2110347564"